Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Tympanogen
AddedFeb 16, 2024
UpdatedJun 18, 2026
Tympanogen

Tympanogen

Pre-Seed

Tympanogen: Innovating ENT care with cost-effective, non-surgical eardrum repair solutions.

HQ
Richmond, VA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Tympanogen, founded with a mission to modernize ENT care, focuses on developing innovative materials that improve treatment outcomes and reduce healthcare costs for otolaryngologists and their patients. The company's flagship product, Perf-Fix, is a pioneering gel patch designed for nonsurgical eardrum repair, aiming to become the standard of care in this field. Tympanogen's solutions are designed to streamline workflows for ENT surgeons and enhance patient experiences, with a market focus on outpatient ENT care.

Notable affiliated individuals and investors include recipients of significant grants from prestigious institutions. Tympanogen has been awarded a substantial grant from the National Institutes of Health to accelerate clinical studies of Perf-Fix. This recognition underscores the company's potential impact on the healthcare industry. Through its innovative approach, Tympanogen is poised to transform ENT procedures, making them more accessible and cost-effective, thereby significantly improving patient outcomes.

Tympanogen - Similar Companies

Entratympanic logo

Entratympanic

entratympanic.com

ENT Surgical logo

ENT Surgical

PionEar Technologies logo

PionEar Technologies

pionear-tech.com

Auricle logo

Auricle

auricle.com

GeniPhys logo

GeniPhys

geniphys.com

Otologic Technologies logo

Otologic Technologies

otologictech.com

OtoKinetics logo

OtoKinetics

ENT Biotech Solutions logo

ENT Biotech Solutions

TalexMedical logo

TalexMedical

infantear.com

Preceptis Medical logo

Preceptis Medical

Audio Bionics logo

Audio Bionics

BioCircuit Technologies logo

BioCircuit Technologies

biocircuit.com

OtoNexus Medical Technologies logo

OtoNexus Medical Technologies

otonexus.com

Oto logo

Oto

joinoto.com

Hearing Health Science logo

Hearing Health Science

soundbites.com

Tympanogen - Quick Facts

Who are Tympanogen's competitors?

Companies similar to Tympanogen include Entratympanic, ENT Surgical, PionEar Technologies and Auricle.

When was Tympanogen founded?

Tympanogen was founded in 2014.

Where is Tympanogen's headquarters located?

Tympanogen's headquarters is located in Richmond, VA, US.

When was Tympanogen's last funding round?

Tympanogen's most recent funding round was for $1M (USD) in April 2022.

How much has Tympanogen raised to-date?

As of Apr 4, 2022, Tympanogen has raised a total of $3.3M (USD).

How many employees does Tympanogen have?

Tympanogen has 8 employees as of Feb 5, 2024.

Tympanogen - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified